S&P DJI Announces March 2026 Quarterly Rebalance
Filed with ASX · · 7 pages · English
Botanix Pharmaceuticals Limited on 6ix
Story so far
Earlier from Botanix Pharmaceuticals
- Appendix 4D and Half Year Report
- Botanix Receives Capital Raise Commitments of A$45 Million
- Trading Halt
- Pause in Trading
- Botanix Quarterly Activities Report and Appendix 4C Q2 FY26
Later from Botanix Pharmaceuticals
- Successful renegotiation of API supply agreement
- Botanix reaches term sheet agreement with 2nd API supplier
- Botanix Quarterly Activities Report and Appendix 4C Q3 FY26
- Intention to Grant a European patent on Sofdra applicator
- Notice of Allowance for US patent on Sofdra drug substance
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals